2012
DOI: 10.1186/1742-4690-9-s2-p50
|View full text |Cite
|
Sign up to set email alerts
|

Design of epitope-specific probes for sera analysis and antibody isolation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
28
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(29 citation statements)
references
References 0 publications
1
28
0
Order By: Relevance
“…Redesigns of the gp120 surface to achieve specific binding to particular antibodies has been instrumental in the development of probes to isolate these antibodies from sera. 28 Redesign of the antibody surface of a gp120-antibody complex has also been effective in optimizing antibody affinity, 25 which is useful for passive immunization and immunogen design. Interestingly, the redesign of the NIH45-46 complex yielded 12 top conformations within 0.06 kcal/mol of each other—two from the top sequence and ten from a double mutant.…”
Section: Resultsmentioning
confidence: 99%
“…Redesigns of the gp120 surface to achieve specific binding to particular antibodies has been instrumental in the development of probes to isolate these antibodies from sera. 28 Redesign of the antibody surface of a gp120-antibody complex has also been effective in optimizing antibody affinity, 25 which is useful for passive immunization and immunogen design. Interestingly, the redesign of the NIH45-46 complex yielded 12 top conformations within 0.06 kcal/mol of each other—two from the top sequence and ten from a double mutant.…”
Section: Resultsmentioning
confidence: 99%
“…More recently, we used OSPREY to predict escape mutations that grant SaDHFR resistance to a different experimental inhibitor, compound 1; we showed that two novel, predicted mutants (V31L and V31G) were selected in resistance selection experiments along with an additional compensating mutation (F98Y) (1). Additionally, we used OSPREY to alter the specificity of Gramicidin S Synthetase A (12, 13), to design epitope-specific HIV antibody probes (14), to design peptides to inhibit the interaction between the protein CAL and cystic fibrosis transmembrane conductance regulator (CFTR) (15), and to screen inhibitors of a leukemia-associated protein-protein interaction (16). Furthermore, the Vaccine Research Center (VRC) used OSPREY to design HIV antibodies that are easier to induce (17).…”
Section: Introductionmentioning
confidence: 99%
“…In this article we describe OSPREY ( O pen S ource P rotein Re design for Y ou), a free, open-source SCPR program. We have prospectively used OSPREY, with experimental validation, to redesign enzymes (Chen et al, 2009), design new drugs (Gorczynski et al, 2007), predict drug resistance (Frey et al, 2010), design peptide inhibitors of protein-protein interactions (Roberts et al, 2012), and design epitope-specific antibody probes (Georgiev, Acharya, et al, 2012). …”
Section: Introductionmentioning
confidence: 99%